Luyang H, Zeng F, Lei Y, He Q, Zhou Y, Xu J
Mol Cancer. 2025; 24(1):22.
PMID: 39819428
PMC: 11737241.
DOI: 10.1186/s12943-025-02228-7.
Fox A, Blazeck J
Metab Eng. 2024; 86:250-261.
PMID: 39490640
PMC: 11611646.
DOI: 10.1016/j.ymben.2024.10.009.
Nandi I, Ji L, Smith H, Avizonis D, Papavasiliou V, Lavoie C
Nat Commun. 2024; 15(1):6587.
PMID: 39097623
PMC: 11297952.
DOI: 10.1038/s41467-024-50998-3.
Guz W, Podgorski R, Bober Z, Aebisher D, Truszkiewicz A, Olek M
Int J Mol Sci. 2024; 25(3).
PMID: 38338997
PMC: 10855746.
DOI: 10.3390/ijms25031719.
Linder S, Bernasocchi T, Martinez-Pastor B, Sullivan K, Galbraith M, Lewis C
Nat Metab. 2023; 5(12):2131-2147.
PMID: 37957387
PMC: 11639397.
DOI: 10.1038/s42255-023-00919-3.
Mitochondria-Mediated Apoptosis of HCC Cells Triggered by Knockdown of Glutamate Dehydrogenase 1: Perspective for Its Inhibition through Quercetin and Permethylated Anigopreissin A.
Marsico M, Santarsiero A, Pappalardo I, Convertini P, Chiummiento L, Sardone A
Biomedicines. 2021; 9(11).
PMID: 34829892
PMC: 8615521.
DOI: 10.3390/biomedicines9111664.
Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
Straub M, Sigman D, Auderset A, Ollivier J, Petit B, Hinnenberg B
BMC Cancer. 2021; 21(1):805.
PMID: 34256713
PMC: 8276491.
DOI: 10.1186/s12885-021-08489-x.
Metabolic programming of tumor associated macrophages in the context of cancer treatment.
Crezee T, Rabold K, de Jong L, Jaeger M, Netea-Maier R
Ann Transl Med. 2020; 8(16):1028.
PMID: 32953828
PMC: 7475452.
DOI: 10.21037/atm-20-1114.
Neutrophil Metabolic Shift during their Lifecycle: Impact on their Survival and Activation.
Injarabian L, Devin A, Ransac S, Marteyn B
Int J Mol Sci. 2020; 21(1).
PMID: 31906243
PMC: 6981538.
DOI: 10.3390/ijms21010287.
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma.
Todisco S, Convertini P, Iacobazzi V, Infantino V
Cancers (Basel). 2019; 12(1).
PMID: 31881713
PMC: 7016696.
DOI: 10.3390/cancers12010068.
Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?.
Jiang J, Srivastava S, Zhang J
Cancers (Basel). 2019; 11(6).
PMID: 31212591
PMC: 6627209.
DOI: 10.3390/cancers11060804.
Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
Mancini R, Noto A, Pisanu M, De Vitis C, Maugeri-Sacca M, Ciliberto G
Oncogene. 2018; 37(18):2367-2378.
PMID: 29445137
DOI: 10.1038/s41388-018-0141-3.
As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid.
Pavlova N, Hui S, Ghergurovich J, Fan J, Intlekofer A, White R
Cell Metab. 2018; 27(2):428-438.e5.
PMID: 29337136
PMC: 5803449.
DOI: 10.1016/j.cmet.2017.12.006.
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.
Zhang J, Pavlova N, Thompson C
EMBO J. 2017; 36(10):1302-1315.
PMID: 28420743
PMC: 5430235.
DOI: 10.15252/embj.201696151.
Glutamine Addiction In Gliomas.
Marquez J, Alonso F, Mates J, Segura J, Martin-Rufian M, Campos-Sandoval J
Neurochem Res. 2017; 42(6):1735-1746.
PMID: 28281102
DOI: 10.1007/s11064-017-2212-1.
The Emerging Hallmarks of Cancer Metabolism.
Pavlova N, Thompson C
Cell Metab. 2016; 23(1):27-47.
PMID: 26771115
PMC: 4715268.
DOI: 10.1016/j.cmet.2015.12.006.
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
Hassanein M, Qian J, Hoeksema M, Wang J, Jacobovitz M, Ji X
Int J Cancer. 2015; 137(7):1587-97.
PMID: 25821004
PMC: 4640891.
DOI: 10.1002/ijc.29535.
Altered glutamine metabolism and therapeutic opportunities for lung cancer.
Mohamed A, Deng X, Khuri F, Owonikoko T
Clin Lung Cancer. 2014; 15(1):7-15.
PMID: 24377741
PMC: 3970234.
DOI: 10.1016/j.cllc.2013.09.001.
Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.
Moreira C, Cassolla P, Dornellas A, de Morais H, Oliveira de Souza C, Borba-Murad G
Int J Exp Pathol. 2013; 94(1):47-55.
PMID: 23317353
PMC: 3575873.
DOI: 10.1111/iep.12002.
SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M, Hoeksema M, Shiota M, Qian J, Harris B, Chen H
Clin Cancer Res. 2012; 19(3):560-70.
PMID: 23213057
PMC: 3697078.
DOI: 10.1158/1078-0432.CCR-12-2334.